Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome.

Hicks MJ, Roth JR, Kozinetz CA, Wang LL.

J Clin Oncol. 2007 Feb 1;25(4):370-5.

PMID:
17264332
2.

Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome.

Wang LL, Gannavarapu A, Kozinetz CA, Levy ML, Lewis RA, Chintagumpala MM, Ruiz-Maldanado R, Contreras-Ruiz J, Cunniff C, Erickson RP, Lev D, Rogers M, Zackai EH, Plon SE.

J Natl Cancer Inst. 2003 May 7;95(9):669-74.

PMID:
12734318
3.

Osteogenic sarcoma in the Rothmund-Thomson syndrome.

Leonard A, Craft AW, Moss C, Malcolm AJ.

Med Pediatr Oncol. 1996 Apr;26(4):249-53. Review.

PMID:
8600336
5.

Metastatic osteosarcoma.

Daw NC, Billups CA, Rodriguez-Galindo C, McCarville MB, Rao BN, Cain AM, Jenkins JJ, Neel MD, Meyer WH.

Cancer. 2006 Jan 15;106(2):403-12.

6.

Rothmund-Thomson syndrome and osteosarcoma.

Cumin I, Cohen JY, David A, Méchinaud F, Avet-Loiseau H, Harousseau JL.

Med Pediatr Oncol. 1996 Jun;26(6):414-6.

PMID:
8614379
7.

Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.

Weiss A, Khoury JD, Hoffer FA, Wu J, Billups CA, Heck RK, Quintana J, Poe D, Rao BN, Daw NC.

Cancer. 2007 Apr 15;109(8):1627-37.

8.

Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients.

Wang LL, Levy ML, Lewis RA, Chintagumpala MM, Lev D, Rogers M, Plon SE.

Am J Med Genet. 2001 Jul 22;102(1):11-7.

PMID:
11471165
10.

Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).

Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K.

J Clin Oncol. 2005 Jan 20;23(3):559-68.

PMID:
15659502
11.

Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.

Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H, Chastagner P, Defaschelles AS, Hartmann O.

Cancer. 2005 Sep 1;104(5):1100-9.

12.

Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.

Petrilli AS, de Camargo B, Filho VO, Bruniera P, Brunetto AL, Jesus-Garcia R, Camargo OP, Pena W, Péricles P, Davi A, Prospero JD, Alves MT, Oliveira CR, Macedo CR, Mendes WL, Almeida MT, Borsato ML, dos Santos TM, Ortega J, Consentino E; Brazilian Osteosarcoma Treatment Group Studies III and IV.

J Clin Oncol. 2006 Mar 1;24(7):1161-8.

PMID:
16505436
13.

[Rothmund-Thomson syndrome and osteosarcoma].

Molina MI, Santolaya JM, Delgado A, Garrote MI, Martínez MR, Indiano JM, Ereño C.

Arch Pediatr. 1995 Sep;2(9):865-70. French.

PMID:
7581784
14.

Therapy-related myelodysplasia in a patient with Rothmund-Thomson syndrome.

Carlson AM, Lindor NM, Litzow MR.

Eur J Haematol. 2011 Jun;86(6):536-40. doi: 10.1111/j.1600-0609.2011.01609.x.

PMID:
21418107
15.

Multicentric osteosarcoma, Rothmund-Thomson syndrome, and secondary nasopharyngeal non-Hodgkin's lymphoma: a case report and review of the literature.

Spurney C, Gorlick R, Meyers PA, Healey JH, Huvos AG.

J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):494-7.

PMID:
9787328
16.

Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999.

Bacci G, Ferrari S, Mercuri M, Longhi A, Fabbri N, Galletti S, Forni C, Balladelli A, Serra M, Picci P.

Acta Orthop. 2007 Jun;78(3):377-84.

PMID:
17611853
17.

Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.

Bacci G, Longhi A, Forni C, Fabbri N, Briccoli A, Barbieri E, Mercuri M, Balladelli A, Ferrari S, Picci P.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):505-11. Epub 2006 Nov 21.

PMID:
17118571
18.

Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site.

Pratt CB, Meyer WH, Rao BN, Pappo AS, Fleming ID, Luo X, Cain A, Kaste SC, Shearer PD, Jenkins JJ 3rd.

Cancer. 1997 Sep 15;80(6):1171-7.

PMID:
9305720
19.

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H.

J Clin Oncol. 2005 Mar 20;23(9):2004-11.

PMID:
15774791
20.

Supplemental Content

Support Center